Table 5 Association between teloscore and MM OS.
From: Genetically determined telomere length and multiple myeloma risk and outcome
Type of score | Quintiles | OS adjusted by stage (DS) | OS adjusted by stage (ISS) | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Alive | Deceased | Total | HR | 95% CI | Pvalue | Alive | Deceased | Total | HR | 95% CI | Pvalue | ||
Unweighted, subjects with 100% call rate | 1 | 158 | 65 | 223 | 1.00 | — | Ref. | 130 | 45 | 175 | 1.00 | — | Ref. |
2 | 142 | 52 | 194 | 1.11 | 0.77–1.60 | 0.564 | 115 | 41 | 156 | 1.21 | 0.78–1.85 | 0.382 | |
3 | 134 | 48 | 182 | 0.98 | 0.67–1.43 | 0.930 | 120 | 36 | 156 | 0.92 | 0.59–1.43 | 0.726 | |
4 | 117 | 42 | 159 | 0.72 | 0.48–1.07 | 0.106 | 164 | 50 | 214 | 0.77 | 0.51–1.15 | 0.210 | |
5 | 133 | 43 | 176 | 0.84 | 0.57–1.24 | 0.393 | 54 | 17 | 71 | 0.89 | 0.50–1.56 | 0.685 | |
Continuousa | 684 | 250 | 934 | 0.93 | 0.85–1.01 | 0.103 | 583 | 189 | 772 | 0.92 | 0.82–1.02 | 0.138 | |
Unweighted scaled, all subjects | 1 | 182 | 92 | 274 | 1.00 | — | Ref. | 152 | 71 | 223 | 1.00 | — | Ref. |
2 | 174 | 77 | 251 | 1.06 | 0.78–1.44 | 0.684 | 139 | 56 | 195 | 1.07 | 0.74–1.52 | 0.716 | |
3 | 172 | 65 | 237 | 0.90 | 0.65–1.24 | 0.538 | 154 | 50 | 204 | 0.83 | 0.57–1.19 | 0.317 | |
4 | 233 | 94 | 327 | 0.84 | 0.63–1.12 | 0.251 | 196 | 69 | 265 | 0.77 | 0.55–1.08 | 0.136 | |
5 | 109 | 37 | 146 | 0.73 | 0.49–1.06 | 0.106 | 102 | 33 | 135 | 0.73 | 0.48–1.12 | 0.154 | |
Continuousa | 870 | 365 | 1235 | 0.93 | 0.85–0.99 | 0.046 | 743 | 279 | 1022 | 0.91 | 0.83–0.99 | 0.037 | |
Weighted, subjects with 100% call rate | 1 | 136 | 54 | 190 | 1.00 | — | Ref. | 119 | 37 | 156 | 1.00 | — | Ref. |
2 | 141 | 54 | 195 | 1.06 | 0.72–1.54 | 0.765 | 111 | 48 | 159 | 1.27 | 0.82–1.96 | 0.268 | |
3 | 127 | 49 | 176 | 1.02 | 0.69–1.50 | 0.917 | 116 | 36 | 152 | 0.94 | 0.59–1.49 | 0.797 | |
4 | 144 | 44 | 188 | 0.72 | 0.48–1.07 | 0.108 | 121 | 30 | 151 | 0.66 | 0.40–1.07 | 0.094 | |
5 | 136 | 49 | 185 | 0.91 | 0.61–1.34 | 0.626 | 116 | 38 | 154 | 1.01 | 0.64–1.60 | 0.933 | |
Continuousa | 684 | 250 | 934 | 0.94 | 0.86–1.03 | 0.198 | 583 | 189 | 772 | 0.94 | 0.84–1.04 | 0.225 | |
Weighted scaled, all subjects | 1 | 168 | 83 | 251 | 1.00 | — | Ref. | 147 | 64 | 211 | 1.00 | — | Ref. |
2 | 167 | 78 | 245 | 1.06 | 0.77–1.44 | 0.722 | 138 | 66 | 204 | 1.06 | 0.75–1.50 | 0.726 | |
3 | 173 | 73 | 246 | 0.97 | 0.70–1.32 | 0.837 | 148 | 51 | 199 | 0.86 | 0.59–1.24 | 0.426 | |
4 | 181 | 66 | 247 | 0.76 | 0.55–1.05 | 0.107 | 158 | 46 | 204 | 0.67 | 0.45–0.98 | 0.042 | |
5 | 181 | 65 | 246 | 0.81 | 0.58–1.12 | 0.210 | 152 | 52 | 204 | 0.82 | 0.57–1.19 | 0.310 | |
Continuousa | 870 | 365 | 1235 | 0.93 | 0.86–0.99 | 0.049 | 743 | 279 | 1022 | 0.92 | 0.84–0.99 | 0.046 |